Ami Organics informs about statement of deviation & variation

12 Feb 2024 Evaluate
Pursuant to Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulation, 2015; Ami Organics has enclosed the statement of deviation(s) or variation(s) in utilisation of Preferential Issue proceeds, for quarter ended December 31, 2023 pertaining to the Preferential Issue of equity shares of the Company in the prescribed format. Further confirmed that, as at December 31, 2023 there has not been any deviation(s) or variation(s) in the utilization of net proceeds of Preferential Issue of equity shares allotted on September 25, 2023.

The above information is a part of company’s filings submitted to BSE. 

Acutaas Chemicals Share Price

1664.30 15.25 (0.92%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×